ChondroFiller for Joint Pain Relief: A Non-Surgical Injection
Insights

ChondroFiller for Joint Pain Relief: A Non-Surgical Injection

Eleanor Hayes

Introduction

Joint pain and joint wear are common and can limit movement and quality of life. Articular cartilage has a very limited ability to repair itself once worn. This article looks at the ChondroFiller injection, a non-surgical collagen-based option used to support the joint and ease pain, with realistic expectations throughout.

How the ChondroFiller Injection Works

ChondroFiller is a Class III CE-marked type I collagen hydrogel scaffold, manufactured by Meidrix Biomedicals in Germany and available in the UK under prescription. When used as an injection, it is delivered as a non-surgical, ultrasound-guided outpatient procedure directly into the joint. Once inside, the gel may settle over worn surfaces, adding a protective collagen layer that helps cushion the joint and reduce direct grinding. Because it is acellular — containing no cells of its own — it relies on the patient's own progenitor cells to engage with the scaffold. It has biological potential, but is best understood as a supportive, joint-preserving injection, not a guaranteed repair, cure, or reversal of arthritis.

It is worth being clear about a distinction that sometimes causes confusion. ChondroFiller is the scaffold device itself; the ChondroFiller injection is its non-surgical delivery pathway — an outpatient procedure with no theatre, no incision, and no general anaesthetic. A separate, genuinely surgical option exists under the name Liquid Cartilage (the Lee Liquid Cartilage Protocol), which is Professor Paul Y. F. Lee's keyhole arthroscopic procedure delivering the ChondroFiller scaffold alongside biological adjuncts and, where indicated, the patient's own mesenchymal stem cells. That surgical route is suitable for larger or load-bearing defects. The two pathways are not the same thing, and this article concerns only the non-surgical injection.

What the Evidence Suggests

Clinical experience with collagen-matrix injections is encouraging but still developing across joints such as the knee, hip, ankle, and thumb base. A 2023 study of an acellular collagen matrix injection for thumb-base osteoarthritis reported improvements in pain and grip strength (Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., and Lavagnolo, U. The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage, 2023). As with most joint treatments, responses vary between individuals and joints, and benefits cannot be guaranteed.

Recovery and Who Benefits Most

Because it is delivered by injection, recovery is usually quicker and easier than surgery, with less trauma to soft tissues and a prompt return to normal activities. It may suit people with osteoarthritis or joint wear in joints such as the knee, hip, or ankle, or early osteoarthritis in smaller joints like the thumb base. Careful assessment, clinical history, and imaging help ensure each person receives a plan suited to their individual circumstances.

What to Expect

Outcomes vary with overall health, the degree of wear, joint stability, and how well post-procedure advice is followed. Many people value reduced pain and easier movement, but benefits cannot be guaranteed. Where the ChondroFiller injection does not provide sufficient relief, other options — including surgical approaches such as the Liquid Cartilage procedure, microfracture, or autologous chondrocyte implantation — can be considered with a specialist, depending on individual circumstances.

Conclusion

The ChondroFiller injection is a non-surgical collagen option that may help support a worn joint and ease pain for some people. Treatment is individualised, with realistic expectations throughout. If you would like advice tailored to your situation, a consultation with a qualified cartilage specialist at the London Cartilage Clinic can help clarify whether the ChondroFiller injection, or another pathway, is most appropriate for you.

References

Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., and Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.

Frequently Asked Questions

  • It is a non-surgical, ultrasound-guided collagen injection that may add a protective, cushioning layer over worn joint surfaces, rather than an operation requiring theatre or anaesthetic. It is not a cure for arthritis, and benefits vary between individuals.
  • No. ChondroFiller is the CE-marked collagen scaffold device. The ChondroFiller injection is the non-surgical delivery pathway — an outpatient injection. Liquid Cartilage refers to Professor Paul Lee's keyhole surgical protocol, which places the ChondroFiller scaffold alongside biological adjuncts during arthroscopic surgery. They are distinct pathways suited to different clinical situations.
  • People with osteoarthritis or joint wear in joints such as the knee, hip, or ankle, or early thumb-base osteoarthritis, who are seeking a non-surgical option may be suitable candidates. Suitability depends on the degree of wear, joint stability, and individual factors assessed during consultation.
  • It is considered very safe, with minor risks mostly linked to the injection procedure itself, such as temporary soreness or mild swelling at the injection site. As with any intra-articular procedure, a specialist will review any relevant contraindications beforehand.
  • As a non-surgical injection, recovery is usually quick, with most people returning to normal activities promptly. Your specialist will give guidance on activity levels and any follow-up assessment needed to monitor the response.

Where to go from here

A few next steps tailored to what you have just read.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at [email protected].

Last reviewed: 2026For urgent medical concerns, contact your local emergency services.

London Cartilage Clinic

Latest Insights

Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.

ChondroFiller and the German cartilage gel alias
ChondroFiller / Liquid Cartilage
Eleanor Hayes

ChondroFiller and the German cartilage gel alias

ChondroFiller® is a CE-marked Class III medical device: a murine-derived collagen scaffold injected as an outpatient procedure that recruits the patient's own cells to regenerate cartilage, delivering functional improvement comparable to two-stage surgical procedures without theatre admission, general anaesthesia, or elevated complication risk.

When hip pain at night means osteoarthritis
Joint Conditions
Eleanor Hayes

When hip pain at night means osteoarthritis

Hip pain waking patients at night or preventing them from lying comfortably on the affected side is a cardinal clinical indicator of osteoarthritis. The joint lining becomes inflamed and does not switch off with rest, making nocturnal pain distinct from ordinary muscular soreness.

Unloader Knee Bracing for Early Cartilage Wear
Knee Cartilage Repair
Eleanor Hayes

Unloader Knee Bracing for Early Cartilage Wear

An unloader brace applies corrective pressure to shift load away from cartilage wear confined to one side of the knee, reducing pain and improving mobility — though benefits require consistent wear and precise fitting.

Privacy & Cookies Policy